Form 8-K - Current report:
SEC Accession No. 0001851734-22-000581
Filing Date
2022-10-03
Accepted
2022-10-03 06:43:04
Documents
17
Period of Report
2022-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdxc20220930_8k.htm   iXBRL 8-K 44235
2 EXHIBIT 10.1 ex_428144.htm EX-10.1 322984
3 EXHIBIT 10.2 ex_428145.htm EX-10.2 226286
4 EXHIBIT 10.3 ex_428148.htm EX-10.3 121770
5 EXHIBIT 10.4 ex_428149.htm EX-10.4 14519
  Complete submission text file 0001851734-22-000581.txt   1021683

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cdxc-20220930.xsd EX-101.SCH 3602
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdxc-20220930_def.xml EX-101.DEF 11533
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdxc-20220930_lab.xml EX-101.LAB 15415
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdxc-20220930_pre.xml EX-101.PRE 11689
11 EXTRACTED XBRL INSTANCE DOCUMENT cdxc20220930_8k_htm.xml XML 2592
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 221285893
SIC: 2833 Medicinal Chemicals & Botanical Products